Neuropace Stock Forecast
NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 9:41 AM ET
NPCE analyst consensus
Consensus (10 analysts)
none
Avg. price target
$20.00+59.59%
- Strong buy 1
- Buy 9
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 10 Wall Street analysts covering Neuropace (2026-10-08), 10 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $20.00, with a high estimate of $22.00 and a low estimate of $18.00. The average target implies upside of 59.6% from the current price of $12.53.
The spread between the highest and lowest targets is 22.2%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NPCE.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 10% |
| Buy | 9 | 90% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $18.00 | +43.63% |
| Average target | $20.00 | +59.59% |
| High target | $22.00 | +75.54% |